# Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

> **NCT01897831** · PHASE4 · UNKNOWN · sponsor: **Xiangbei Welman Pharmaceutical Co., Ltd** · enrollment: 2000 (estimated)

## Conditions studied

- Respiratory Tract Infections
- Urinary Tract Infections

## Interventions

- **DRUG:** xin te mie

## Key facts

- **NCT ID:** NCT01897831
- **Lead sponsor:** Xiangbei Welman Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-11
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2013-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01897831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01897831, "Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01897831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*